Pharmaceutical expenditure and total health-care expenditure in OECD countries and China: bidirectional Granger causality on the basis of health level-Reference-Cited by-同舟云学术

Pharmaceutical expenditure and total health-care expenditure in OECD countries and China: bidirectional Granger causality on the basis of health level

Published:2019-04-08 Issue: Volume: Page:1-8
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Xiong Yuqi¹,Cui Youwen¹,Zhang Xinping¹

Affiliation:

1. School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China

Funder

National Natural Science Foundation of China

Major Program of National Fund of Philosophy and Social Science of China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2019.1605292

Reference70 articles.

1. Pharmaceutical expenditure, total health-care expenditure and GDP

2. Health Care Spending in the United States and Other High-Income Countries

3. Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan

4. The dynamic relationship between health expenditure and economic growth: is the health-led growth hypothesis valid for Turkey?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical consumption, economic growth and life expectancy in the OECD: the application of a new causal direction from dependency algorithm and a DeepNet process;Journal of Economic Studies;2024-06-11

2. A quasi-experimental study of the volume-based procurement (VBP) effect on antiviral medications of hepatitis B virus in China;Frontiers in Pharmacology;2023-09-05

3. A Novel Evaluation of Air Pollution Impact from Stationary Emission Sources to Ambient Air Quality via Time-Series Granger Causality;Earth Data Analytics for Planetary Health;2023

4. Were economic evaluations well reported for the newly listed oncology drugs in China’s national reimbursement drug list;BMC Health Services Research;2022-12-03

5. The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City: An Interrupted Time Series Analysis;Frontiers in Public Health;2021-10-25